Page 5 - Generic Drugs

Branded generics: Uncertainty or opportunity?

The rules of the game in India's branded generics market are fuzzy to say the least

Organised generic drugs chain Medkart Pharmacy plans national foray

By adding over 250 stores in next three years, Medkart is looking to grow its turnover from Rs 20 crore currently to Rs 300 crore in the next three years

Price-fixing charges: Sun Pharma in talks with US to end anti-trust probe

Prosecutors have been investigating allegations that generic drugmakers conspired to prop up the prices of certain widely used medications for more than five years

Pharma industry needs to develop entire value chain: Dr Reddy's G V Prasad

According to Prasad, the relevance of Indian pharma sector as a provider of affordable alternative to the world remains intact

Sun Pharma announces tie-up for China foray; to develop 8 generic products

The total addressable market size for all these eight products is about $1 billion (according to recent IQVIA data) in mainland China

'Affordable' drive: Govt asks chemists to display generic drugs prominently

Experts believe the move will have little impact given limited production of generic drugs and authority of doctors in prescribing medicines.

Why public health facilities are failing to meet demand for generic drugs

Over 35% of the generic and branded drugs were purchased from private facilities across all survey sites

Lupin, Dr Reddy's, Glenmark and Taro see up to 40% decline in the US sales

Except a few, large pharmaceutical players see up to 40% decline in the US sales

Approval for generics drug up but US business shrinks for home firms

The trend is likely to continue for the next few quarters before the benefit from new drug launches start to accrue

Generic drug approvals on the rise in US; 101 applications get nod in Oct

Since April, top Indian firms have secured approvals for 203 drugs: Edelweiss Securities report

Prescribe the right pill

Doctors must be encouraged to prescribe generic drugs and not specific brands

Take the generic drug, patients are told - unless insurers say no

Pharma firms are cutting deals with insurance comapnies to favour their brand over cheaper generics

Ensuring that generics replace branded drugs

Substituting branded drugs with generics will be a challenging journey

Prescribing generic drugs will reduce patient confusion & medication errors

Drug names are long, complex and there are usually multiple brands for the same product

Jan Aushadhi may get a new life in the time of generic drugs

At a time when the government is trying to make prescription of generics compulsory, the Prime Minister's Jan Aushadhi Yojana is in the limelight once again. As a large portion of unbranded generics is sold either in Jan Aushadhi stores or chemists at government hospitals, the government's flagship project promising drugs at affordable prices is likely to get a renewed push, according to officials. Launched in 2008 as Jan Aushadhi Scheme under the UPA regime, it was renamed Pradhan Mantri Jan Aushadhi Yojana or PMJAY by the current NDA government. While the stores continue to be known as Jan Aushadhi, a rebranding exercise has been initiated for the outlets now. A move is on to rename all Jan Aushadhi stores as PMJAY, it is learnt. In fact, social media has been abuzz, referring to the project as ''PM ki jay'' (victory for the PM)."In the process of re-branding, chief ministers will be asked to inaugurate at least a few stores, with the new name", said a government official. The ...

Only 230 generic drugs available at AIIMS' medical store

MCI warned doctors of action if they fail to adhere to guideline on prescribing generic drugs

Doctors will now prescribe only generic drugs or face action, warns council

MCI has asked the medical community to follow its 2016 notification

In generics we trust

The patient can go to the pharmacist and pick up the brand of his choice

Modi govt plan on generic drugs makes pharma companies, doctors jittery

The Narendra Modi govt is planning to bring law to make doctors compulsorily prescribe generic drugs

EU recommends suspending 300 generic drugs tested by Indian firm

Many large drugmakers have been shifting more critical trials back to the US